Literature DB >> 24460526

Myocardial iron overload in thalassaemia major. How early to check?

Caterina Borgna-Pignatti1, Antonella Meloni, Giulia Guerrini, Letizia Gulino, Aldo Filosa, Giovan B Ruffo, Tommaso Casini, Elisabetta Chiodi, Massimo Lombardi, Alessia Pepe.   

Abstract

The age at which it is necessary to start Cardiovascular Magnetic Resonance (CMR) T2* screening in thalassaemia major (TM) is still uncertain. To clarify this point, we evaluated the prevalence of myocardial iron overload (MIO), function and fibrosis by CMR in TM patients younger than 10 years. We retrospectively selected 35 TM patients enrolled in the Myocardial Iron Overload in Thalassaemia network. MIO was measured by T2* multislice multiecho technique. Biventricular function parameters were evaluated by cine images. To detect myocardial fibrosis, late gadolinium enhancement images were acquired. Patients' age ranged from 4·2 to 9·7 years. All scans were performed without sedation. Nine patients showed no MIO, 22 patients had heterogeneous MIO with a T2* global value ≥20 ms; two patients had heterogeneous MIO with a T2* global value <20 ms and two patients showed homogeneous MIO. No patient showed myocardial fibrosis. Among the patients with heart T2*<20 ms, the youngest was 6 years old, none showed heart dysfunction and the iron transfused was <35 g in all cases. Cardiac iron loading can occur much earlier than previously described. The first cardiac T2* assessment should be performed as early as feasible without sedation, especially if chelation is started late or if poor compliance is suspected.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  heart; iron overload; magnetic resonance; paediatric; thalassaemia major

Mesh:

Year:  2014        PMID: 24460526     DOI: 10.1111/bjh.12643

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major.

Authors:  Fadime Ersoy Dursun; Gönül Açıksarı; Serçin Özkök; Onur İncealtın
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-08       Impact factor: 2.357

2.  Cardiac MRI for Iron Overload in pediatric thalassemia patients- Right Age to Start in a Resource Constrained Environment.

Authors:  Khushboo Pilania; Bhavin Jankharia; Aamish Kazi
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-05       Impact factor: 0.915

3.  Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.

Authors:  Ruwangi Dissanayake; Nayana Samarasinghe; Samantha Waidyanatha; Sajeewani Pathirana; Nilaksha Neththikumara; Vajira H W Dissanayake; Kalum Wetthasinghe; Lallindra Gooneratne; Pujitha Wickramasinghe
Journal:  BMC Pediatr       Date:  2022-06-15       Impact factor: 2.567

4.  Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients.

Authors:  Karn Wijarnpreecha; Natthaphat Siri-Angkul; Krekwit Shinlapawittayatorn; Pimlak Charoenkwan; Suchaya Silvilairat; Chate Siwasomboon; Pannee Visarutratna; Somdet Srichairatanakool; Adisak Tantiworawit; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

5.  T2* assessment of the three coronary artery territories of the left ventricular wall by different monoexponential truncation methods.

Authors:  Pandji Triadyaksa; Jelle Overbosch; Matthijs Oudkerk; Paul Eduard Sijens
Journal:  MAGMA       Date:  2022-04-18       Impact factor: 2.533

Review 6.  Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.

Authors:  Alina Sadaf; Babar Hasan; Jai K Das; Steven Colan; Najveen Alvi
Journal:  Cochrane Database Syst Rev       Date:  2018-07-12

Review 7.  Cardiac T2 * mapping: Techniques and clinical applications.

Authors:  Pandji Triadyaksa; Matthijs Oudkerk; Paul E Sijens
Journal:  J Magn Reson Imaging       Date:  2019-12-14       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.